SMTL ID : 5dh5.1 (1 other biounit)

PDE10 complexed with N-[(1-methylpyrazol-4-yl)methyl]-5-[[(1S,2S)-2-(2-pyridyl)cyclopropyl]methoxy]pyrazolo[1,5-a]pyrimidin-7-amine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 6 residues within 4Å: Chain A: H.81, H.85, H.119, D.120, D.230 Ligands: MG.2 6 PLIP interactions: 4 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:H.85, A:H.119, A:D.120, A:D.230, H2O.1, H2O.1

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 3 residues within 4Å: Chain A: D.120, E.148 Ligands: ZN.1 6 PLIP interactions: 1 interactions with chain A, 5 Ligand-Water interactions Metal complexes: A:D.120, H2O.1, H2O.1, H2O.2, H2O.3, H2O.3

1 x 5AY: N-[(1-methyl-1H-pyrazol-4-yl)methyl]-5-{[(1S,2S)-2-(pyridin-2-yl)cyclopropyl]methoxy}pyrazolo[1,5-a]pyrimidin-7-amine(Non-covalent)

5AY.3: 13 residues within 4Å: Chain A: Y.80, H.81, L.231, S.233, V.234, I.248, Y.249, F.252, M.269, E.277, G.281, Q.282, F.285 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.234, A:I.248, A:F.252, A:M.269, A:F.285 Hydrogen bonds: A:Y.249, A:Q.282 Water bridges: A:Y.80 pi-Stacking: A:H.81, A:F.285

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Raheem, I.T. et al., Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia. Bioorg.Med.Chem.Lett. (2016)

Release Date

2016-01-27

Peptides

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A

Related Entries With Identical Sequence